Eli Lilly & Co’s Promising Growth: Accelerated Revenue and Drug Pipeline Advances
DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating on January 21.Invest with Confidence: Follow ...
Morningstar22h
MFS Massachusetts Inv Gr Stk A
Nine stocks—Apple, Microsoft, Amazon.com, Nvidia, Alphabet, Tesla, Broadcom, Eli Lily, and Meta Platforms—accounted for nearly 60% of the Russell 1000 Growth Index as of September 2024.